Inventaire - your friends and communities are your best library

Immunological monitoring of anticancer vaccines in clinical trials

published in: OncoImmunology

date of publication: 2013-08-23

main subject: immunology

Cites articles 36

Date

Title

Authors

2013-03-01

Clinical evaluation of therapeutic cancer vaccines
2012-03-15

The immune contexture in human tumours: impact on clinical outcome

Jérôme Galon
2012-01-24

Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited

Gerhard Opelz
2012-04-01

An international multicenter randomized controlled trial of G17DT in patients with pancreatic cancer.
2012-01-03

The immune score as a new possible approach for the classification of cancer

Jérôme Galon, Franck Pagès, Paolo Antonio Ascierto, Francesco Marincola, Thomas F Gajewski, Bernard A Fox, Magdalena Thurin, Giorgio Trinchieri
2011-05-31

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

Franco Muggia, Elaine Jaffe, Sattva S Neelapu, Larry W Kwak
2011-05-31

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
2011-05-14

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer

Miguel Martin
2011-01-18

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Marie Tosolini, Wolf Hervé Fridman, Jérôme Galon, Patrick Bruneval, Bernhard Mlecnik, Zlatko Trajanoski, Gabriela Bindea, Amos Kirilovsky, Franck Pagès, Tchao Meatchi
2010-10-27

NGcGM3 ganglioside: a privileged target for cancer vaccines
2010-02-01

A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma

Richard G Ghalie, Peter H. Wiernik
2009-08-01

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

John Nemunaitis
2009-05-04

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma

Richard G Ghalie, Paul Hamlin, Benjamin Djulbegovic, Sattva S Neelapu
2008-07-03

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Bernard Escudier
2008-04-30

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
2008-02-01

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group

Luis H Camacho, Alessandro Testori, Bruce Mann
2008-06-01

Allovectin-7 therapy in metastatic melanoma

Michele Del Vecchio
2007-09-01

Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
2007-02-01

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Wataru Yamagami, Atsushi Nakajima, Setsuo Hirohashi, Nobuyoshi Hiraoka
2007-01-01

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma

Sattva S Neelapu
2007-03-01

G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy
2006-04-01

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

Vernon K Sondak
2006-06-05

Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses

Mitchell Smith, Peter H. Wiernik
2005-10-01

Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).

Enriqueta Felip, Giuseppe Giaccone
2005-03-01

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
2004-10-13

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype
2003-12-01

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine

Donald Morton
2003-09-09

Disease-driven T cell activation predicts immune responses to vaccination against melanoma
2003-12-22

Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine
2003-02-01

Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma

Anne Zeleniuch-Jacquotte
2002-10-01

Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer

Roy Pounder
2000-12-01

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

Article - wd:Q42734281

Welcome to Inventaire

the library of your friends and communities

learn more